NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

體外診斷設備的全球市場:各產品,各終端用戶的預測(到2025年)- COVID-19累積的影響

In-Vitro Diagnostics Instrument Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 989826
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
體外診斷設備的全球市場:各產品,各終端用戶的預測(到2025年)- COVID-19累積的影響 In-Vitro Diagnostics Instrument Market Research Report by Product, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

全球體外診斷設備的市場規模,預計從2020年的188億1,822萬美元擴大到2025年末達272億7,638萬美元。

COVID-19是影響幾乎全部產業的無與倫比的世界公共衛生緊急事件,在預測期間內預計帶給產業的成長長期性的影響。

本報告提供全球體外診斷設備市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19累積的影響,各產品、各終端用戶、各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 規定事項
  • 利害關係者

第2章 調查方法

  • 調查流程
    • 定義:調查目的
    • 決策:調查計劃
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場展望
  • 各產品市場展望
  • 各終端用戶市場展望
  • 各地區市場的展望
  • 其他競爭公司的展望

第4章 市場概要

  • 簡介
  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 各產品市場

  • 簡介
  • 臨床微生物學
  • 血液學
  • 止血
  • 免疫化學
  • 分子診斷
  • POCT
  • SMBG
  • 組織診斷

第7章 各終端用戶市場

  • 簡介
  • 學術、研究機關
  • 居家醫療
  • 醫院及診斷研究所

第8章 南北美洲市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太地區市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第10章 歐洲,中東、非洲市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第11章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第12章 企業簡介

  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Danaher Corporation
  • Diasorin S.P.A.
  • Johnson & Johnson
  • Ortho-Clinical Diagnostics, Inc.
  • Qiagen N.V.
  • Roche Diagnostics
  • Siemens AG
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc

第13章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-43127F7279FC

The Global In-Vitro Diagnostics Instrument Market size was estimated at USD 19.05 Billion in 2020 and expected to reach USD 20.59 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.39% to reach USD 30.90 Billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the In-Vitro Diagnostics Instrument to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the In-Vitro Diagnostics Instrument Market was studied across Clinical Microbiology, Hematology, Hemostasis, Immunochemistry, Molecular Diagnostics, POCT, SMBG, and Tissue Diagnostics.

Based on End User, the In-Vitro Diagnostics Instrument Market was studied across Academic & Research Institutes, Homecare, and Hospitals & diagnostic laboratories.

Based on Geography, the In-Vitro Diagnostics Instrument Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the In-Vitro Diagnostics Instrument Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global In-Vitro Diagnostics Instrument Market, including Abbott Laboratories, Inc., Accelerate Diagnostics, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Caris Life Sciences, Inc., Danaher Corporation, Diasorin S.P.A., Genomeme, Genspeed Biotech Gmbh, Grifols, Hologic, Illumina, Instrumentation Laboratory / Werfen, Johnson & Johnson, LabCorp, Laboratory Corporation of America, Luminex, MSDX, Ortho-Clinical Diagnostics, Inc., PerkinElmer, Philips, Qiagen N.V., Quidel, Roche Diagnostics, Siemens AG, Siemens Healthineers, Speedx Diagnostics, Sysmex Corporation, and Thermo Fisher Scientific, Inc.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global In-Vitro Diagnostics Instrument Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Instrument Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Instrument Market?
  • 4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Instrument Market?
  • 5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Instrument Market?
  • 6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Instrument Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Instrument Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Product Outlook
  • 3.4. End User Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and significant prevalence of chronic and infectious diseases
      • 5.1.1.2. Increasing adoption and availability of fully automated and POC instruments in developed regions
      • 5.1.1.3. Increased awareness about disease indication & diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Non-favourable reimbursement options
    • 5.1.3. Opportunities
      • 5.1.3.1. Targeted product development and commercialization
      • 5.1.3.2. Collaborative research and product development
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. In-Vitro Diagnostics Instrument Market, by Product

  • 6.1. Introduction
  • 6.2. Clinical Microbiology
  • 6.3. Hematology
  • 6.4. Hemostasis
  • 6.5. Immunochemistry
  • 6.6. Molecular Diagnostics
  • 6.7. POCT
  • 6.8. SMBG
  • 6.9. Tissue Diagnostics

7. In-Vitro Diagnostics Instrument Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Homecare
  • 7.4. Hospitals & diagnostic laboratories

8. Americas In-Vitro Diagnostics Instrument Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States
    • 8.6.1. California
    • 8.6.2. Florida
    • 8.6.3. Illinois
    • 8.6.4. New York
    • 8.6.5. Ohio
    • 8.6.6. Pennsylvania
    • 8.6.7. Texas

9. Asia-Pacific In-Vitro Diagnostics Instrument Market

  • 9.1. Introduction
  • 9.2. China
  • 9.3. India
  • 9.4. Indonesia
  • 9.5. Japan
  • 9.6. Malaysia
  • 9.7. Philippines
  • 9.8. South Korea
  • 9.9. Thailand

10. Europe, Middle East & Africa In-Vitro Diagnostics Instrument Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Quadrant
  • 11.4. Market Share Analysis, By Company
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott Laboratories, Inc.
  • 12.2. Accelerate Diagnostics, Inc.
  • 12.3. Becton, Dickinson and Company
  • 12.4. Bio-Rad Laboratories, Inc.
  • 12.5. Biomerieux SA
  • 12.6. Caris Life Sciences, Inc.
  • 12.7. Danaher Corporation
  • 12.8. Diasorin S.P.A.
  • 12.9. Genomeme
  • 12.10. Genspeed Biotech Gmbh
  • 12.11. Grifols
  • 12.12. Hologic
  • 12.13. Illumina
  • 12.14. Instrumentation Laboratory / Werfen
  • 12.15. Johnson & Johnson
  • 12.16. LabCorp, Laboratory Corporation of America
  • 12.17. Luminex
  • 12.18. MSDX
  • 12.19. Ortho-Clinical Diagnostics, Inc.
  • 12.20. PerkinElmer
  • 12.21. Philips
  • 12.22. Qiagen N.V.
  • 12.23. Quidel
  • 12.24. Roche Diagnostics
  • 12.25. Siemens AG
  • 12.26. Siemens Healthineers
  • 12.27. Speedx Diagnostics
  • 12.28. Sysmex Corporation
  • 12.29. Thermo Fisher Scientific, Inc

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
  • 13.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
  • FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2020 (USD BILLION)
  • FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD BILLION)
  • FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: MARKET DYNAMICS
  • FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CLINICAL MICROBIOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CLINICAL MICROBIOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMATOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMOSTASIS, 2018-2026 (USD BILLION)
  • FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMOSTASIS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOCHEMISTRY, 2018-2026 (USD BILLION)
  • FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2026 (USD BILLION)
  • FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY POCT, 2018-2026 (USD BILLION)
  • FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY POCT, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 22. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SMBG, 2018-2026 (USD BILLION)
  • FIGURE 23. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SMBG, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 24. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TISSUE DIAGNOSTICS, 2018-2026 (USD BILLION)
  • FIGURE 25. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TISSUE DIAGNOSTICS, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 26. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2020 VS 2026 (USD BILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2026
  • FIGURE 29. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2026 (USD BILLION)
  • FIGURE 30. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 31. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOMECARE, 2018-2026 (USD BILLION)
  • FIGURE 32. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 33. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2026 (USD BILLION)
  • FIGURE 34. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 35. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 36. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 38. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 39. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 40. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 41. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 42. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 43. CALIFORNIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 44. FLORIDA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 45. ILLINOIS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 46. NEW YORK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 47. OHIO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 48. PENNSYLVANIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 49. TEXAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 50. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 51. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 52. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 53. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 54. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 55. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 56. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 57. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 58. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 59. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 60. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 61. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 62. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD BILLION)
  • FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 64. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 65. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 66. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 67. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 68. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 69. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 70. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 71. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 72. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 73. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 74. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD BILLION)
  • FIGURE 75. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 76. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 77. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 78. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CLINICAL MICROBIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMATOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 6. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMOSTASIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOCHEMISTRY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY POCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SMBG, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TISSUE DIAGNOSTICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOMECARE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 16. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 17. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 18. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 19. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 20. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 21. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 22. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 23. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 24. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 25. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 26. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 27. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 28. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 29. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 30. CALIFORNIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 31. CALIFORNIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 32. FLORIDA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 33. FLORIDA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 34. ILLINOIS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 35. ILLINOIS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 36. NEW YORK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 37. NEW YORK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 38. OHIO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 39. OHIO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 40. PENNSYLVANIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 41. PENNSYLVANIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 42. TEXAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 43. TEXAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 44. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 45. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 46. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 47. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 48. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 49. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 50. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 51. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 52. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 53. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 54. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 55. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 56. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 57. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 58. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 59. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 60. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 61. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 62. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 66. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 67. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 68. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 69. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 70. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 71. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 72. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 73. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 74. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 75. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 76. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 77. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 78. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 79. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 80. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 81. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 82. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 83. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 84. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 85. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 86. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 87. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD BILLION)
  • TABLE 88. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: SCORES
  • TABLE 89. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: BUSINESS STRATEGY
  • TABLE 90. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: PRODUCT SATISFACTION
  • TABLE 91. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: RANKING
  • TABLE 92. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 93. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 94. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: MERGER & ACQUISITION
  • TABLE 95. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 96. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 97. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: INVESTMENT & FUNDING
  • TABLE 98. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 99. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: LICENSE & PRICING
  • TABLE 100. GLOBAL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET: CONTACT DETAILS